Vous êtes sur la page 1sur 3

The Complimentary and Alternative Medicine Academic Society (CAMAS) in collaboration with the

Society of Endobiogenic Medicine and Integrative Physiology UK (SEMIP-UK) presents:

Depression: A re-evaluation of the role of serotonin and

new approaches to treatment in Endobiogenic Medicine
with Dr. Jean-Claude Lapraz
This% talk% will% re-evaluate% the% concept% of% depression% and%
the%hypothesis%that% serotonin%is%the%cause%of%depression.%
Based% on% an% integrative% approach% to% physiology%
according% to% the% theory% of% Endobiogenic% Medicine,% we%
will% explore% if% serotonin% is% a% cause% or% a% mechanism% in%
in% depression% will% also% be% explored.% By% the% end% of% the%
lecture,% new% approaches% to% the% diagnosis% and% treatment%
of% depression% will% be% presented% based% on% the% causes% of%

SEMIP-UK is a society whose primary purpose is

to coordinate information, and provide training,
resources, and support on Endobiogenic
Medicine for the UK public and medical



Sat. 19 March, 2016

10:00 am 5:00 pm
TBA, Middlesex University,
The Burroughs, London NW4 4BT
15 CAMAS student members
25 non-members
Note refreshments will be provided.

About Dr. Lapraz

Jean-Claude Lapraz, MD is a French medical doctor and co-developer, along
with Christian Duraffourd, MD, of what is now known as Endobiogenic Medicine
and previously as clinical phytotherapy.
Drs. Lapraz and Duraffourd have been developing this model since the early
1970s, and Dr. Lapraz has spent the last 30 or so years training medical
practitioners in endobiogenic medicine as well as rigorously testing the
therapeutic capabilities of medicinal plants in a clinical setting, both in private
practice and in hospital care.
Indeed, Dr. Lapraz was a consultant in the General Surgery and Oncology Department of the Hpital Boucicaut in
Paris from 1989-1996, where he used Endobiogenic Medicine principles and medicinal plants as part of cancer
treatment protocols. He also worked with Pasteur Institute researchers, and at other leading institutions worldwide
applying Endobiogenic Medicine to a range of medical challenges from fibromyalgia to cholera and leprosy.
Dr. Lapraz participated in the creation of the National Diploma of Clinical Phytotherapy in France in 1982 and has
helped set up clinical trainings both in France and abroad including in Belgium, Spain, England, Greece, Italy,
Mexico, Switzerland, Ivory Coast, Tunisia and USA.
He has worked in close collaboration with official bodies (including the Ministry of Health and the European
Parliament) since 1977, participating in several ministerial commissions and drawing up a report on the state of
phytotherapy in France for the Ministry of Health in 1985.
Dr. Lapraz has lectured at many universities both in France and abroad; carried out clinical research, hospital trials,
studies and evaluations on botanical medicine; written articles and contributed to medical journals; and written and
published a number of books on phytotherapy and Endobiogenic Medicine.
For specific information on any of these studies, articles and books,
please contact SEMIP-UK.

About Endobiogenic Medicine

Endobiogenic Medicine is an integrative whole systems model. It is based on developmental and

systems biology and physiology, and evaluates the internal life of the body (the terrain) through the use
of a particular physical examination, medical history and an innovative blood test called the Biology of
Function. This blood analysis is unlike any other blood test currently available. Indeed it differs from
other blood tests in a number of ways, namely by determining biological activity through over 150 direct
and indirect markers, and evaluating quantitative as well as qualitative function in the body. It is an
invaluable tool to help understand, prevent and treat dis-ease.
Endobiogenic Medicines systemic and integrative perspective enables practitioners to gain a more
global, deep and complex understanding of dis-ease processes and how to restore optimal balance in
the system as a whole.
The treatment strategy in Endobiogenic Medicine is personalized to the specific internal imbalances of
the patient as well as external circumstances. The best treatment for the patient is the one that is most
targeted for them and offers the greatest chance of restoring the endogenous regulatory mechanisms. A
rational clinical approach to medicinal plants is favoured due to its ability to reintroduce dynamic
regulatory capability and buffering capacity to the organism. Nutritional and lifestyle recommendations
are personalized to the disorder, chronobiologic, and epigenetic considerations.